Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20210717051914N2
IRCT20210717051914N2
Recruiting
Phase 3

Investigating the effect of selenium supplementation on disease activity, serum levels of some oxidative stress factors, anti-ds DNA antibody (Anti-ds DNA) and high sensitivity C-reactive protein (hs CRP) in patients with systemic lupus erythematosus (LES) .

Ahvaz University of Medical Sciences0 sites56 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
56
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age 15 to 60 years
  • •Having at least four of the clinical and immunological diagnostic criteria for systemic lupus erythematosus
  • •Body mass index equal to and less than 35

Exclusion Criteria

  • •Suffering from other autoimmune and rheumatological diseases
  • •Pregnancy and breastfeeding
  • •Severe liver diseases
  • •Severe renal failure
  • •Severe and active infections
  • •Taking selenium supplements during the last two months
  • •Recent excessive consumption of antioxidant supplements (such as vitamin C, vitamin E, omega 3, etc.) or their consumption during the intervention
  • •History of allergy to selenium supplements
  • •Other cancers
  • •Body mass index above 35

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0
IRCT20201129049534N6Esfahan University of Medical Sciences60
Recruiting
Phase 3
The effect of selenium on cancer related-fatigueCancer-related fatigue.Neoplasm-related fatigueR53.0
IRCT20210825052293N1Esfahan University of Medical Sciences70
Completed
Phase 3
Selenium supplementation in the treatment of hemodialysis patients
IRCT20170513033941N62Islamic Azad University40
Completed
Phase 3
Effect of selenium on malnutrition- inflamation complex syndrome (MICS) in hemodialysis patientsEnd stage renal disease , hemodialysis.Chronic renal failure
IRCT138812043408N1Shiraz University of Medical Sciences80
Completed
Phase 3
Determining the effect of Selenium supplementation on CD4+ T lymphocyte count in HIV+ patients refered to Iranian HIV/AIDS Research Center (IRCHA)HIV infection.Unspecified human immunodeficiency virus [HIV] disease
IRCT138904244380N2Vice Chancellor For Research, Tehran University of Medical Sciences100